Pear therapeutics developed new reSET-A™ PDT product candidate for the treatment of alcohol use disorder (AUD)
PDTsare new therapeutic class designed with software to directly treat disease. Similar to traditional medicines, PDT’s are developed and tested in a randomized controlledtrials and demonstrates safety and effectiveness.
Currently, there are few treatment options for AUD patients with less than 2 percent of patients receiving medication for treating AUD.There are no FDA approved prescribed digital therapeutics or medical devices available for people with AUD-only.
In U.S, alcohol is one of the most commonly consumed substance. According to the survey, it was stated that in the year 2019 around 14 million U.S population including adults aging 18 and older had AUD. Moreover, alcohol related problems has affected approximately 95,000 people’s life leading them to deaths and thus made alcohol as the third main leading cause of death in United States.
U.S. Food and Drug Administration (FDA) grants Breakthrough Therapy designation for reSET-A™ PDT product candidateto treat alcohol use disorder (AUD).
